2G1N

Ketopiperazine-based renin inhibitors: Optimization of the "C" ring


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.9 Å
  • R-Value Free: 0.285 
  • R-Value Work: 0.212 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Ketopiperazine-based renin inhibitors: Optimization of the "C" ring

Holsworth, D.D.Cai, C.Cheng, X.M.Cody, W.L.Downing, D.M.Erasga, N.Lee, C.Powell, N.A.Ednunds, J.J.Stier, M.Jalaie, M.Zhang, E.McConnell, P.Ryan, M.J.Bryant, J.Li, T.Kasani, A.Hall, E.Subedi, R.Rahim, M.Maiti, S.

(2006) BIOORG.MED.CHEM.LETT. 16: 2500-2504

  • DOI: 10.1016/j.bmcl.2006.01.084
  • Primary Citation of Related Structures:  2FS4, 2G1O, 2G1R, 2G1S, 2G1Y, 2G20, 2G21, 2G22, 2G24, 2G26, 2G27

  • PubMed Abstract: 
  • A systematic investigation of the S3 sub-pocket activity requirements was conducted. It was observed that linear and sterically small side chain substituents are preferred in the S3 sub-pocket for optimal renin inhibition. Polar groups in the S3-sub- ...

    A systematic investigation of the S3 sub-pocket activity requirements was conducted. It was observed that linear and sterically small side chain substituents are preferred in the S3 sub-pocket for optimal renin inhibition. Polar groups in the S3-sub-pocket were not well tolerated and caused a reduction in renin inhibitory activity. Further, compounds with clog P's < or = 3 demonstrated a dramatic reduction in CYP3A4 inhibitory activity.


    Organizational Affiliation

    Pfizer Global Research and Development, Michigan Laboratories, Department of Chemistry, Ann Arbor, MI 48105, USA. Daniel.Holsworth@pfizer.com




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Renin
A, B
333Homo sapiensGene Names: REN
EC: 3.4.23.15
Find proteins for P00797 (Homo sapiens)
Go to Gene View: REN
Go to UniProtKB:  P00797
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
1IG
Query on 1IG

Download SDF File 
Download CCD File 
A, B
N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE
C20 H26 N6 O2 S
RMEVNJZCKDVVND-UHFFFAOYSA-N
 Ligand Interaction
NAG
Query on NAG

Download SDF File 
Download CCD File 
A, B
N-ACETYL-D-GLUCOSAMINE
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.9 Å
  • R-Value Free: 0.285 
  • R-Value Work: 0.212 
  • Space Group: P 21 3
Unit Cell:
Length (Å)Angle (°)
a = 142.027α = 90.00
b = 142.027β = 90.00
c = 142.027γ = 90.00
Software Package:
Software NamePurpose
CNSrefinement

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2006-02-14 
  • Released Date: 2006-06-13 
  • Deposition Author(s): Holsworth, D.D.

Revision History 

  • Version 1.0: 2006-06-13
    Type: Initial release
  • Version 1.1: 2008-05-01
    Type: Version format compliance
  • Version 1.2: 2011-07-13
    Type: Non-polymer description, Version format compliance